Genky DrugStores Co., Ltd.

Genky DrugStores Co., Ltd.

TTSE:9267
3,855.00
JPY
-55.00
(-1.41%)
252.40EPS
13.60P/E
105.12BMarket Cap
Feb 02Next Earn
Genky DrugStores Co., Ltd.
TSE:9267
(Tokyo Stock Exchange)

Recent

price

3,855.00

P/E

ratio

13.60

div

yld

- -

ROIC.AI

2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
TTM
JPY
1,875.94
2,062.28
1,983.05
1,048.54
2,260.78
2,608.52
2,956.98
3,141.9
3,364.32
4,071.98
4,690.45
5,093.66
5,567.39
6,086.29
6,591.04
7,259.54
7,355.52
Revenue per Share
32.93
41.62
22.61
21.19
63.06
67.48
100.9
103.27
87.35
90.76
159.17
145.59
156.89
208.21
231.95
259.11
253.26
Basic EPS, GAAP
19.72
-34.65
-100.06
21.34
-58.04
-176.25
-43.04
2.49
-207.97
-118.42
102.81
-145.92
-38.04
92.68
-82.39
-104.24
- -
Free Cash Flow per Basic Share
5.29
6.23
6.25
3.13
6.88
7.53
8.73
12.21
12.52
12.5
12.5
12.48
12.48
12.51
12.97
13
- -
Dividend per Share
247.49
282.45
299.11
334.22
387
446.16
538.16
769.03
833.8
912.07
1,059.7
1,193.22
1,339.57
1,536.31
1,757.7
2,011.74
2,066.69
Book Value per Share
243.69
279.74
293.88
328.79
378.21
437.31
529.11
760.47
824.21
902.08
1,046.72
1,180.9
1,327.62
1,523.87
1,747.6
2,003.02
2,057.88
Tangible Book Value per Share
27
27
28
55
28
28
28
30
31
30
30
30
30
30
30
30
30
Basic Weighted Avg Shares
51,517
56,701
54,656
57,950
63,144
73,496
83,400
94,869
103,897
123,603
142,376
154,639
169,059
184,860
200,786
220,638
224,099
Sales/Revenue/Turnover
2.62
3.39
1.64
3.28
4.34
3.61
4.62
4.35
3.9
3.51
4.42
3.67
3.97
4.88
4.81
4.98
4.83
Operating Margin (%)
1,040
1,173
1,356
1,454
1,553
2,189
2,614
2,910
3,320
3,761
4,059
4,592
4,955
5,566
6,292
7,133
- -
Depreciation Expense
904
1,144
623
1,171
1,761
1,901
2,846
3,118
2,698
2,755
4,832
4,420
4,764
6,324
7,066
7,875
7,716
Net Income, GAAP
43.56
44.37
38.72
41.27
38.02
33.68
30.42
28.14
30.59
31.67
27.48
27.34
28.92
28.15
28.64
29.38
29.43
Effective Tax Rate (%)
1.76
2.02
1.14
2.02
2.79
2.59
3.41
3.29
2.6
2.23
3.39
2.86
2.82
3.42
3.52
3.57
3.44
Profit Margin (%)
-3,009
-1,817
-1,380
-2,160
-4,663
-6,083
-5,631
-4,779
-2,946
319
-2,501
-6,133
-5,703
-3,512
-2,602
-3,588
-2,702
Working Capital
3,171
4,410
7,304
6,775
7,867
10,896
13,210
8,738
16,036
24,422
21,710
20,762
21,093
22,553
25,956
30,153
30,736
LT Debt
6,797
7,785
8,244
9,270
10,894
12,584
15,178
23,805
25,310
27,686
32,166
36,232
40,680
46,679
53,427
61,372
63,060
Total Equity
6.47
8.04
3.39
5.88
7.87
6.58
8.19
8.05
6.47
5.53
7.55
6.34
6.71
8.45
8.17
8.05
7.8
Return on Invested Capital (%)
8.33
9.22
4.16
6.56
8.69
7.47
9.04
8.73
6.42
5.31
8.2
6.98
6.87
8.51
8.74
8.58
8.23
Return on Capital (%)
14.11
15.69
7.77
13.37
17.47
16.2
20.5
16
10.98
10.4
16.15
12.92
12.39
14.48
14.12
13.72
13.04
Return on Common Equity (%)

Capital Structure

JPY

•

in mil. unless spec.
Mar'26
Jun'26
Sep'27
ST Debt
10,384
9,487
9,738
LT Borrowings
28,220
30,020
30,736
LT Finance Leases
- -
133
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
30
31
31
Market Capitalization
120,697
102,961
105,116

Working Capital

JPY

•

in mil. unless spec.
Mar'26
Jun'26
Sep'27
Total Current Assets
47,643
46,121
51,813
Cash, Cash Equivalents & STI
11,390
7,866
13,928
Accounts Receivable, Net
5,902
5,667
5,901
Inventories
26,933
28,654
28,092
Total Current Liabilities
50,638
49,709
54,515
Payables & Accruals
- -
- -
- -
ST Debt
10,384
9,487
9,738
Deferred Revenue
- -
- -
- -

Growth Rates

JPY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
17.84%
13.8%
14.87%
Free Cash Flow
-988.05%
-164.51%
26.22%
Net Income, GAAP
17.85%
11.04%
11.45%
Sales/Revenue/Turnover
11.67%
9.16%
9.89%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
50,050
48,708
48,625
53,403
200,786
2026
56,042
53,219
52,449
58,928
220,638
2027
59,503
- -
- -
- -
- -

Quarterly Earnings Per Share

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
52.13
55.4
52.8
72.15
231.95
2026
66.76
65.1
52.49
73.88
259.11
2027
61.78
- -
- -
- -
- -

Quarterly Dividends Per Share

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
12.97
2026
- -
- -
- -
- -
13
2027
- -
- -
- -
- -
- -
Business
Genky DrugStores Co., Ltd. (9267.T) operates as a holding company overseeing a chain of discount drugstores in Japan that retail medicines, over-the-counter drugs, cosmetics, miscellaneous goods, health and wellness supplements, personal care products, household items, and food products; the company emphasizes private-label brands, which account for about 30% of sales and offer discounts relative to national brands, alongside prescription medications and pharmaceutical consultation services. Founded in 1988 and headquartered at 38-33 Shimokumeda, Maruoka-cho, Sakai City, Fukui Prefecture, Japan, Genky DrugStores manages approximately 1,841 employees and focuses on rural and declining markets with stores averaging 1,000 square meters, providing one-stop shopping for daily necessities where food represents roughly 70% of sales. The company vertically integrates store development, logistics, and real estate acquisition to support operational efficiency; it serves general consumers through an expanding network, reporting net sales of 200.8 billion yen for the fiscal year ended June 2025, with all-store sales growth of 9.1% in November 2025 and existing store sales up 2.2%. In recent developments, Genky DrugStores opened 54 new stores in the last fiscal year and targets 66 additional stores with 10% overall growth in fiscal 2026; it transitioned to a pure holding company structure in December 2017, enabling focused group management of its operating subsidiary while driving consistent revenue expansion outpacing Japan's retail averages at 9.5% annually.